ABOUT US

Locally Targeted Sustained Delivery

Purgo Scientific is a medical device company, that has been created for one reason, to bring to market an effective locally targeted sustained delivery device to be used in orthopedic surgery.
  • Versatile medical device
  • Easy to place, refill, and remove
  • FDA clearance in process
View the Science

ABOUT US

Locally Targeted Sustained Delivery

Purgo Scientific is a medical device company, that has been created for one reason, to bring to market an effective locally targeted sustained delivery devise to be used in orthopedic surgery.
  • Versatile medical device.
  • Easy to Place, Refill, and Remove.
  • FDA Clearance In Process.
View the Science

ABOUT US

Locally Targeted Sustained Delivery

Purgo Scientific is a medical device company, that has been created for one reason, to bring to market an effective locally targeted sustained delivery devise to be used in orthopedic surgery.
  • Versatile medical device.
  • Easy to Place, Refill, and Remove.
  • FDA Clearance In Process.
View the Science

“The global impact of surgical site infections is monumental and as many as 80% of these infections may involve a microbial biofilm.”

Edmiston C.E., McBain A.J., Roberts C., Leaper D. (2015) Clinical and Microbiological Aspects of Biofilm-Associated Surgical Site Infections. In: Donelli G. (eds) Biofilm-based Healthcare-associated Infections. Advances in Experimental Medicine and Biology, vol 830. Springer, Cham. https://doi.org/10.1007/978-3-319-11038-7_3 

R1_300x_3

“The global impact of surgical site infections is monumental and as many as 80% of these infections may involve a microbial biofilm.”

Edmiston C.E., McBain A.J., Roberts C., Leaper D. (2015) Clinical and Microbiological Aspects of Biofilm-Associated Surgical Site Infections. In: Donelli G. (eds) Biofilm-based Healthcare-associated Infections. Advances in Experimental Medicine and Biology, vol 830. Springer, Cham. https://doi.org/10.1007/978-3-319-11038-7_3 

“The global impact of surgical site infections is monumental and as many as 80% of these infections may involve a microbial biofilm.”

Edmiston C.E., McBain A.J., Roberts C., Leaper D. (2015) Clinical and Microbiological Aspects of Biofilm-Associated Surgical Site Infections. In: Donelli G. (eds) Biofilm-based Healthcare-associated Infections. Advances in Experimental Medicine and Biology, vol 830. Springer, Cham. https://doi.org/10.1007/978-3-319-11038-7_3 

PURGO TEAM

Leading The Science of Drug Delivery

Michael Benjamin - Chief Executive Officer

Michael Benjamin

Executive Board Chair

Experience President – Benjamin Enterprises, A technology & resource development...

Dustin Williams, PHD

Dustin Williams, PhD

Science Advisory Board Chair

Experience Ph.D. – Bioengineering from the University of Utah. B.S....

Michael Benjamin - Chief Executive Officer

Michael Benjamin

Chief Executive Officer

Experience President – Benjamin Enterprises, A technology & resource development...

Dustin Williams, PHD

Dustin Williams, PhD

Chief Science Officer

Experience Ph.D. – Bioengineering from the University of Utah. B.S....

Nicolas Ashton

Nicolas Ashton, PhD

Chief Technology Officer

Chief Technology Officer

Brian Barnum

Brian Barnum

Principal Engineer

Principal Engineer

Angy Guerrant

Angy Guerrant

VP of Operations

VP of Operations

Jeremy Shaw MD ORS

Jeremy Shaw, MD

Susan Winckler, RHp, Esq

Susan Winckler, RHp, Esq

Board Secretary

Experience CEO – Reagan-Udall Foundation for the Food and Drug...

{"cpt":"team","style":"1","columns":"6","show":6,"order":"DESC","orderby":"none"}

PURGO TEAM

Leading The Science of Drug Delivery

Shannon Whitmore

Shannon Whitmore

Managing Director, Pivot Point, VP Compliance, Purgo Scientific
{"cpt":"team","style":"1","columns":"3","show":6,"order":"DESC","orderby":"none"}

PURGO TEAM

Leading the Science
of Drug Delivery

Shannon Whitmore

Shannon Whitmore

Managing Director, Pivot Point, VP Compliance, Purgo Scientific

Surgical Site Infection Annual cost to the U.S. healthcare system up to 

$10 BILLION

Surgical Site Infection Annual cost to the U.S. healthcare system up to

$10 BILLION

Surgical Site Infection Annual cost to the
U.S. healthcare system up to

$10 BILLION

Surgical Site Infection – By the Numbers in U.S.

Surgical Site
Infection – By the
 Numbers in U.S.

Number of U.S. patients
affected by SSI annually.
0 K
Average number of days
in hospital due to SSI.
0
Number of U.S. patients
that die from SSI annually.
0 K
Number of U.S.
patients affected
by SSI annually.
0 K
Average number of
days in hospital
due to SSI.
0
Number of U.S.
patients that die
from SSI annually.
0 K
Cause of healthcare
acquired infections.
# 0
Cause of hospital
readmissions after surgery.
# 0
Number of U.S. patients
affected by SSI annually.
0 K
Average number of days
in hospital due to SSI.
0
Number of U.S. patients
that die from SSI annually.
0 K
Cause of healthcare
acquired infections.
# 0
Cause of hospital
readmissions after surgery.
# 0

Home

Copyright © 2024 Purgo Scientific, All Rights Reserved. Site by Design on Edge